Global Neuropeptide Y Receptor Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 149693
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 122
  • list Medical Devices

Neuropeptide Y (NPY) receptors are involved in different types of biological processes. It is a class of G-Protein coupled receptors sensitive to closely associated peptide hormones such as peptide YY, pancreatic polypeptide, and neuropeptide Y. NPY is closely related to central mechanism involving obesity and food intake; however the topic is still a part of extensive medical research.

Scope of the Report:

Increase in prevalence of various diseases related to obesity and surge in overweight populace drives the market.

Moreover, unhealthy urban lifestyle and increase in number of fast food eating populace susceptible to sudden weight gain, is expected to boost the market growth.

However, number of limited manufacturers and distribution channels is anticipated to impede the market growth.

The worldwide market for Neuropeptide Y Receptor is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Neuropeptide Y Receptor in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Gila Therapeutics

Novo Nordisk

XL-protein

Lilly Eli

Novartis

Pfizer

Merck & Co

Mannkind

Gilead Sciences

Genentech

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Food Grade

Pharmaceutical Grade

Market Segment by Applications, can be divided into

Medicine

Food Additives

Others

There are 15 Chapters to deeply display the global Neuropeptide Y Receptor market.

Chapter 1, to describe Neuropeptide Y Receptor Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Neuropeptide Y Receptor, with sales, revenue, and price of Neuropeptide Y Receptor, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Neuropeptide Y Receptor, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Neuropeptide Y Receptor market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Neuropeptide Y Receptor sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Neuropeptide Y Receptor Introduction

1.2 Market Analysis by Type

1.2.1 Food Grade

1.2.2 Pharmaceutical Grade

1.3 Market Analysis by Applications

1.3.1 Medicine

1.3.2 Food Additives

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Gila Therapeutics

2.1.1 Business Overview

2.1.2 Neuropeptide Y Receptor Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Gila Therapeutics Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Novo Nordisk

2.2.1 Business Overview

2.2.2 Neuropeptide Y Receptor Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novo Nordisk Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 XL-protein

2.3.1 Business Overview

2.3.2 Neuropeptide Y Receptor Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 XL-protein Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Lilly Eli

2.4.1 Business Overview

2.4.2 Neuropeptide Y Receptor Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Lilly Eli Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novartis

2.5.1 Business Overview

2.5.2 Neuropeptide Y Receptor Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novartis Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Pfizer

2.6.1 Business Overview

2.6.2 Neuropeptide Y Receptor Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pfizer Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck & Co

2.7.1 Business Overview

2.7.2 Neuropeptide Y Receptor Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck & Co Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Mannkind

2.8.1 Business Overview

2.8.2 Neuropeptide Y Receptor Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Mannkind Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Gilead Sciences

2.9.1 Business Overview

2.9.2 Neuropeptide Y Receptor Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Gilead Sciences Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Genentech

2.10.1 Business Overview

2.10.2 Neuropeptide Y Receptor Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Genentech Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Neuropeptide Y Receptor Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Neuropeptide Y Receptor Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Neuropeptide Y Receptor Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Neuropeptide Y Receptor Manufacturer Market Share in 2017

3.3.2 Top 6 Neuropeptide Y Receptor Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Neuropeptide Y Receptor Market Analysis by Regions

4.1 Global Neuropeptide Y Receptor Sales, Revenue and Market Share by Regions

4.1.1 Global Neuropeptide Y Receptor Sales and Market Share by Regions (2013-2018)

4.1.2 Global Neuropeptide Y Receptor Revenue and Market Share by Regions (2013-2018)

4.2 North America Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

4.3 Europe Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

4.5 South America Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

5 North America Neuropeptide Y Receptor by Countries

5.1 North America Neuropeptide Y Receptor Sales, Revenue and Market Share by Countries

5.1.1 North America Neuropeptide Y Receptor Sales and Market Share by Countries (2013-2018)

5.1.2 North America Neuropeptide Y Receptor Revenue and Market Share by Countries (2013-2018)

5.2 United States Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

5.3 Canada Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

5.4 Mexico Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

6 Europe Neuropeptide Y Receptor by Countries

6.1 Europe Neuropeptide Y Receptor Sales, Revenue and Market Share by Countries

6.1.1 Europe Neuropeptide Y Receptor Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Neuropeptide Y Receptor Revenue and Market Share by Countries (2013-2018)

6.2 Germany Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

6.3 UK Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

6.4 France Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

6.5 Russia Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

6.6 Italy Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

7 Asia-Pacific Neuropeptide Y Receptor by Countries

7.1 Asia-Pacific Neuropeptide Y Receptor Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Neuropeptide Y Receptor Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Neuropeptide Y Receptor Revenue and Market Share by Countries (2013-2018)

7.2 China Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

7.3 Japan Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

7.4 Korea Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

7.5 India Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

8 South America Neuropeptide Y Receptor by Countries

8.1 South America Neuropeptide Y Receptor Sales, Revenue and Market Share by Countries

8.1.1 South America Neuropeptide Y Receptor Sales and Market Share by Countries (2013-2018)

8.1.2 South America Neuropeptide Y Receptor Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

8.3 Argentina Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

8.4 Colombia Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

9 Middle East and Africa Neuropeptide Y Receptor by Countries

9.1 Middle East and Africa Neuropeptide Y Receptor Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Neuropeptide Y Receptor Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Neuropeptide Y Receptor Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

9.3 UAE Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

9.4 Egypt Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

9.5 Nigeria Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

9.6 South Africa Neuropeptide Y Receptor Sales and Growth Rate (2013-2018)

10 Global Neuropeptide Y Receptor Market Segment by Type

10.1 Global Neuropeptide Y Receptor Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Neuropeptide Y Receptor Sales and Market Share by Type (2013-2018)

10.1.2 Global Neuropeptide Y Receptor Revenue and Market Share by Type (2013-2018)

10.2 Food Grade Sales Growth and Price

10.2.1 Global Food Grade Sales Growth (2013-2018)

10.2.2 Global Food Grade Price (2013-2018)

10.3 Pharmaceutical Grade Sales Growth and Price

10.3.1 Global Pharmaceutical Grade Sales Growth (2013-2018)

10.3.2 Global Pharmaceutical Grade Price (2013-2018)

11 Global Neuropeptide Y Receptor Market Segment by Application

11.1 Global Neuropeptide Y Receptor Sales Market Share by Application (2013-2018)

11.2 Medicine Sales Growth (2013-2018)

11.3 Food Additives Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Neuropeptide Y Receptor Market Forecast (2018-2023)

12.1 Global Neuropeptide Y Receptor Sales, Revenue and Growth Rate (2018-2023)

12.2 Neuropeptide Y Receptor Market Forecast by Regions (2018-2023)

12.2.1 North America Neuropeptide Y Receptor Market Forecast (2018-2023)

12.2.2 Europe Neuropeptide Y Receptor Market Forecast (2018-2023)

12.2.3 Asia-Pacific Neuropeptide Y Receptor Market Forecast (2018-2023)

12.2.4 South America Neuropeptide Y Receptor Market Forecast (2018-2023)

12.2.5 Middle East and Africa Neuropeptide Y Receptor Market Forecast (2018-2023)

12.3 Neuropeptide Y Receptor Market Forecast by Type (2018-2023)

12.3.1 Global Neuropeptide Y Receptor Sales Forecast by Type (2018-2023)

12.3.2 Global Neuropeptide Y Receptor Market Share Forecast by Type (2018-2023)

12.4 Neuropeptide Y Receptor Market Forecast by Application (2018-2023)

12.4.1 Global Neuropeptide Y Receptor Sales Forecast by Application (2018-2023)

12.4.2 Global Neuropeptide Y Receptor Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Neuropeptide Y Receptor Picture

Table Product Specifications of Neuropeptide Y Receptor

Figure Global Sales Market Share of Neuropeptide Y Receptor by Types in 2017

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery